Author

D. Calvisi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

M. Evert· 2 shared X. Chen· 2 shared A. Cigliano· 1 shared A. Coluccio· 1 shared A. Pocaterra· 1 shared A. Scheiter· 1 shared A. Teufel· 1 shared C. Ament· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

M. Evert

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

RASSF1A independence and early Galectin-1 upregulation in PIK3CA induced hepatocarcinogenesis: new therapeutic venues

A. Scheiter, K. Evert, L. Reibenspies, A. Cigliano, K. Annweiler, K. Mueller, L.-M.-G. Poehmerer, T. Itzel, S. Materna-Reichelt, A. Coluccio, K. Honarnejad, A. Teufel, C. Brochhausen, F. Dombrowski, X. Chen, , K. Utpatel

This study shows that PIK3CA mutations drive hepatocarcinogenesis independently of RASSF1A status, with early Galectin-1 upregulation and synergistic therapeutic effects of PIK3CA and Galectin-1 inhibitors.

bioRxiv · Jun 15, 2021Pathology

Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development

A. Pocaterra, C. Ament, S. Ribbak, M. Evert, X. Chen, D. Calvisi, S. Dupont

This study identifies Fascin1 as a regulator of YAP mechanotransduction that promotes cholangiocarcinoma development by sustaining YAP activation in response to ECM cues.

bioRxiv · Nov 18, 2020Cancer Biology